Reference
Advisory Committee on Safety of Medicinal Products (ACSoMP): Measures to minimize the risk of ocular adverse events with miltefosine Internet Document : 12 Apr 2023. Available from: URL: https://www.who.int/news/item/12-04-2023-acsomp-miltefosine
Rights and permissions
About this article
Cite this article
Measures to reduce risk of miltefosine-related eye disorders. Reactions Weekly 1954, 4 (2023). https://doi.org/10.1007/s40278-023-37822-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-37822-0